Every person's immune system is unique, so are the habits that their tumors thrive in, so how can we rapidly find immunotherapies that work? Our live coverage from AACR. Continue reading
Humanized mice are evolving in immuno-oncology research and opening the door to more precise ways of treating patients. Continue reading
DIPG is a brain stem tumor that is always fatal in children. What are we doing to try and change those dismal odds? Our live coverage of AACR continues. Continue reading
An unusual business model that encourages transparency is trying to beat a rare and deadly childhood cancer Continue reading
Will pairing PARP inhibitors with immunotherapies achieve more effective outcomes in breast cancer patients? Our coverage at AACR continues. Continue reading
How an international group vies to bring pediatric oncology drugs to clinic faster using an innovative platform Continue reading
Pediatric cancer is generally defined as cancer in a patient age 14 or younger, though some definitions increase the age to 19. Take our quiz to test your knowledge of childhood cancers.
Combination therapies, deciphering the tumor microenvironment, studying rare cancers and AI are important tools in fighting cancer more precisely Continue reading